Please assess the completion status of the following clinical trial:

Trial Title: Mobile Phones in Cryptogenic Stroke Patients Bringing Single Lead ECGs to Detect Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must have had an episode of symptomatic Transient ischemic attack (TIA) or episode of ischemic stroke.~  * Ischemic stroke is defined as an episode of transient or neurological dysfunction caused by focal brain or retinal ischemia with recent infarction on imaging~ * A TIA is defined as transient episode of neurologic dysfunction typically lasting less than one hour caused by focal brain or retinal ischemia without recent infarction on imaging.~Exclusion Criteria:~* Known etiology of TIA or ischemic stroke~* TIA or stroke caused by spinal ischemia~* TIA only presenting with non-localising symptoms~* Uncertainty about the diagnosis of TIA because of unclear clinical symptoms~* Myocardial infarction \<6 months before stroke~* Coronary Artery Bypass Grafting \<6 months before stroke~* Severe valvular heart disease~* Documented history of atrial fibrillation or atrial flutter~* Permanent indication for oral anticoagulation at enrolment~* Patient has permanent OAC contraindication~* Patient is included in another randomized trial~* Left ventricular aneurysm on echocardiography~* Thrombus on echocardiographyRenal dysfunction (creatinine clearance \<30 mL/min/1.73m2)~* Patient has life expectancy of \<1 year~* Patient is not willing to sign the informed consent form~* Patient is \<18 years of age~* Patient is considered an incapacitated adult~* Patient is not in possession of a smartphone with Android Operating System (OS) or iOS.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 7-Day Holter monitor (Type: ACTIVE_COMPARATOR): This arm will receive a 7-Day Holter monitor directly after randomization.
- Single lead ECG device (Type: EXPERIMENTAL): This arm will be asked to take a single lead ECG two times per day and in case of complaints with a single lead ECG device.

Based on this trial design, predict the completion outcome and termination type (if applicable).